Wealth Enhancement Advisory Services, LLC Compugen LTD Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Compugen LTD stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,313 shares of CGEN stock, worth $17,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,313Holding current value
$17,325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
78Shares Held
13.7MCall Options Held
15.2KPut Options Held
41.3K-
Silverarc Capital Management, LLC3.31MShares$5.56 Million0.98% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.41MShares$2.36 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.06MShares$1.78 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.71 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC965KShares$1.62 Million0.73% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $146M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...